Your browser doesn't support javascript.
loading
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.
Lloyd-Price, Jason; Arze, Cesar; Ananthakrishnan, Ashwin N; Schirmer, Melanie; Avila-Pacheco, Julian; Poon, Tiffany W; Andrews, Elizabeth; Ajami, Nadim J; Bonham, Kevin S; Brislawn, Colin J; Casero, David; Courtney, Holly; Gonzalez, Antonio; Graeber, Thomas G; Hall, A Brantley; Lake, Kathleen; Landers, Carol J; Mallick, Himel; Plichta, Damian R; Prasad, Mahadev; Rahnavard, Gholamali; Sauk, Jenny; Shungin, Dmitry; Vázquez-Baeza, Yoshiki; White, Richard A; Braun, Jonathan; Denson, Lee A; Jansson, Janet K; Knight, Rob; Kugathasan, Subra; McGovern, Dermot P B; Petrosino, Joseph F; Stappenbeck, Thaddeus S; Winter, Harland S; Clish, Clary B; Franzosa, Eric A; Vlamakis, Hera; Xavier, Ramnik J; Huttenhower, Curtis.
Afiliação
  • Lloyd-Price J; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Arze C; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Ananthakrishnan AN; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Schirmer M; Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
  • Avila-Pacheco J; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Poon TW; Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
  • Andrews E; Metabolomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Ajami NJ; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Bonham KS; Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
  • Brislawn CJ; Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
  • Casero D; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Courtney H; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Gonzalez A; Earth and Biological Sciences Directorate, Pacific Northwest National Lab, Richland, WA, USA.
  • Graeber TG; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Hall AB; Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
  • Lake K; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
  • Landers CJ; Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA.
  • Mallick H; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Plichta DR; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Prasad M; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Rahnavard G; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Sauk J; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Shungin D; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Vázquez-Baeza Y; Department of Pediatrics, Emory University, Atlanta, GA, USA.
  • White RA; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Braun J; Vatche and Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA, USA.
  • Denson LA; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Jansson JK; Department of Odontology, Umeå University, Umeå, Sweden.
  • Knight R; Jacobs School of Engineering, University of California San Diego, La Jolla, CA, USA.
  • Kugathasan S; Center for Microbiome Innovation, University of California San Diego, La Jolla, CA, USA.
  • McGovern DPB; Earth and Biological Sciences Directorate, Pacific Northwest National Lab, Richland, WA, USA.
  • Stappenbeck TS; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Winter HS; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Clish CB; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Franzosa EA; Earth and Biological Sciences Directorate, Pacific Northwest National Lab, Richland, WA, USA.
  • Vlamakis H; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
  • Xavier RJ; Center for Microbiome Innovation, University of California San Diego, La Jolla, CA, USA.
  • Huttenhower C; Department of Computer Science and Engineering, University of California San Diego, La Jolla, CA, USA.
Nature ; 569(7758): 655-662, 2019 05.
Article em En | MEDLINE | ID: mdl-31142855
ABSTRACT
Inflammatory bowel diseases, which include Crohn's disease and ulcerative colitis, affect several million individuals worldwide. Crohn's disease and ulcerative colitis are complex diseases that are heterogeneous at the clinical, immunological, molecular, genetic, and microbial levels. Individual contributing factors have been the focus of extensive research. As part of the Integrative Human Microbiome Project (HMP2 or iHMP), we followed 132 subjects for one year each to generate integrated longitudinal molecular profiles of host and microbial activity during disease (up to 24 time points each; in total 2,965 stool, biopsy, and blood specimens). Here we present the results, which provide a comprehensive view of functional dysbiosis in the gut microbiome during inflammatory bowel disease activity. We demonstrate a characteristic increase in facultative anaerobes at the expense of obligate anaerobes, as well as molecular disruptions in microbial transcription (for example, among clostridia), metabolite pools (acylcarnitines, bile acids, and short-chain fatty acids), and levels of antibodies in host serum. Periods of disease activity were also marked by increases in temporal variability, with characteristic taxonomic, functional, and biochemical shifts. Finally, integrative analysis identified microbial, biochemical, and host factors central to this dysregulation. The study's infrastructure resources, results, and data, which are available through the Inflammatory Bowel Disease Multi'omics Database ( http//ibdmdb.org ), provide the most comprehensive description to date of host and microbial activities in inflammatory bowel diseases.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Microbioma Gastrointestinal Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Microbioma Gastrointestinal Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article